Testing effectiveness (Phase 2)Study completedNCT05104463
What this trial is testing
CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease
Who this might be right for
Mild Cognitive ImpairmentDementia
CuraSen Therapeutics, Inc. 64